Company Ticker News March 8, 2022Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular disease portfolio 0 0 Share
Press Release February 23, 2022Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark 0 0 Share
Company Ticker News February 3, 2022Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests 0 0 Share
Press Release January 29, 2022FDA Approves Genentech's Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss 0 0 Share
Press Release January 24, 2022The Lancet Publishes Studies Showing Genentech's Faricimab Improved and Maintained Vision in Two Leading Causes of Vision Loss, Extending Time Between Treatments up to Four Months 0 0 Share
Press Release January 24, 2022The Lancet publishes studies showing Roche's faricimab improved and maintained vision in two leading causes of vision loss, extending time between treatments up to four months 0 0 Share
Press Release January 11, 2022Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare 0 0 Share
Press Release December 25, 2021Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States 0 0 Share
Press Release December 3, 2021Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant 0 0 Share
